Skip to main content
Neuland Labs

Main navigation

  • CDMO Services
    • Small Molecules
    • Peptides
  • Generic APIs
    • API Products
    • Download Brochure
  • Our Capabilities
    • Chemistry & Reactions
    • Peptide Technologies
    • Lifecycle Management (Phase-Appropriate Development)
    • Quality & Regulatory Compliance
    • Technology Transfer
    • Analytical Expertise
    • Process Safety & Engineering
  • Contact us
User account menu
  • Log in
By Anonymous (not verified), 27 July, 2026

Loss of SC - 13062018

Disclosures to Stock Exchange
2018-19
NA
PDF
loss-of-sc-13062018.pdf (2.35 MB)
By Anonymous (not verified), 27 July, 2026

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Disclosures to Stock Exchange
2018-19
NA
PDF
disclosures-under-reg-31(1)-and-31(2)-of-sebi-(sast)-regulations-2011.pdf (155.52 KB)
By Anonymous (not verified), 27 July, 2026

Change in Management Appointment of Director

Disclosures to Stock Exchange
2018-19
NA
PDF
change-in-management-appointment-of-director.pdf (114.91 KB)
By Anonymous (not verified), 27 July, 2026

Update In Respect Of Fund Raising By Issuance Of Debt Securities By Large Entities

Disclosures to Stock Exchange
2019-20
NA
PDF
update-in-respect-of-fund-raising-by-issuance-of-debt-securities-by-large-entities.pdf (50.12 KB)
By Anonymous (not verified), 27 July, 2026

Submission Of Half Yearly Disclosure On Related Party Transactions Pursuant To Regulation 23(9)

Disclosures to Stock Exchange
2019-20
NA
PDF
submission-of-half-yearly-disclosure-on-related-party-transactions-pursuant-to-regulation-23(9).pdf (94.34 KB)
By Anonymous (not verified), 27 July, 2026

Resignation of Chief Financial Officer (CFO)

Disclosures to Stock Exchange
2019-20
NA
PDF
resignation-of-chief-financial-officer-(cfo).pdf (49.43 KB)
By Anonymous (not verified), 27 July, 2026

Reg 24(A) - Annual Secretarial Compliance

Disclosures to Stock Exchange
2019-20
NA
PDF
reg-24(a)-annual-secretarial-compliance.pdf (1.08 MB)
By Anonymous (not verified), 27 July, 2026

Reg 30 US FDA Inspection

Disclosures to Stock Exchange
2019-20
NA
PDF
reg-30-us-fda-inspection.pdf (48.32 KB)
By Anonymous (not verified), 27 July, 2026

Reg 30 US FDA Inspection Unit I

Disclosures to Stock Exchange
2019-20
NA
PDF
reg-30-us-fda-inspection-unit-I.pdf (47.78 KB)
By Anonymous (not verified), 27 July, 2026

Initial Disclosure to be made by an entity identified as a Large Corporate FY2020

Disclosures to Stock Exchange
2019-20
NA
PDF
initial-disclosure-to-be-made-by-an-entity-identified-as-a-large-corporate-fy2020.pdf (50.12 KB)

Pagination

  • First page
  • Previous page
  • …
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Page 61
  • Page 62
  • Page 63
  • …
  • Next page
  • Last page
RSS feed
Powered by Drupal